Boult Wade Tennant
/bulletin

Archives: Bulletins

June 19, 2025

G1/24: The Enlarged Board of Appeal issues its decision

In G1/24, the EPO Enlarged Board ruled that claims must always be interpreted in light of the description and drawings when assessing patentability, even if the claims appear clear on their own.

Use of the EPO’s problem-and-solution approach for assessing inventive step at the UPC

The UPC’s Court of First Instance confirms the EPO’s problem-and-solution approach as the main method for assessing inventive step, ensuring consistency and legal certainty across Europe.

June 18, 2025

Go ask Alice

In Alice Ltd v Photogram, the High Court upheld ALICE’s trade mark, confirming infringement and dismissing revocation. A reminder: even modest, well-documented use can protect broad rights.

June 17, 2025

The AI Continent Action Plan – The EU’s bid to become a global leader in AI

The EU’s AI Continent Action Plan aims to make Europe a global AI leader by enhancing infrastructure, expanding data access, fostering talent, and building a strong regulatory framework.

June 12, 2025

No time restriction on competence of the UPC

The UPC now has confirmed authority over pre-UPCA infringements, even during opt-out periods. This landmark decision reshapes jurisdiction expectations.

June 11, 2025

UK’s green transition: Rising patent filings and the quest for green skilled talent

As UK green tech patents surge, a talent gap threatens progress. Boult helps innovators protect ideas, access funding, and turn sustainable vision into reality with smart IP strategies.

June 10, 2025

R&D funding and the Patent Box for green tech start-ups: Mini series part three

This part of our green tech funding series covers the UK Patent Box—a scheme offering 10% corporation tax on profits from patented IP. Learn eligibility, timing, income types, and R&D credit links.

INTA 2026 in London

INTA 2026 is coming to London. We’ve produced a handy guide to help you with your planning including where to stay and eat.

June 6, 2025

Offending life and human dignity?

EPO decision T1553/22 rejects a patent on human-pig chimeras, citing ethical concerns under Article 53(a) EPC due to risks to human dignity from pluripotent stem cell use.

June 3, 2025

Dr Michelle Pratt in conversation with Daryl Penny, Partner, European Patent Attorney, and UPC Representative at Boult.

Daryl Penny shares insights on EPO oppositions, UPC litigation, team strategy, and career advice from 23+ years in patents. A must-read for those navigating European IP law.